673 related articles for article (PubMed ID: 11762572)
1. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
2. [Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003].
Donker GA; Groenhof F; van der Veen WJ
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1742-7. PubMed ID: 16114292
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
[TBL] [Abstract][Full Text] [Related]
4. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
5. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
Huissoud T; Jeannin A; Dubois-Arber F
Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
[TBL] [Abstract][Full Text] [Related]
6. Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.
Boland F; Galvin R; Reulbach U; Motterlini N; Kelly D; Bennett K; Fahey T
BMC Pediatr; 2015 Sep; 15():118. PubMed ID: 26357902
[TBL] [Abstract][Full Text] [Related]
7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
8. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
9. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
Schubert I; Köster I; Lehmkuhl G
Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
[TBL] [Abstract][Full Text] [Related]
10. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
11. A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy.
Sluiter MN; de Vries YA; Koning LG; Hak E; Bos JHJ; Schuiling-Veninga CCM; Batstra L; Doornenbal JM; de Jonge P
Adm Policy Ment Health; 2020 Mar; 47(2):291-299. PubMed ID: 31620909
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
[TBL] [Abstract][Full Text] [Related]
13. Psychostimulant prescriptions by psychiatrists higher than expected: a self-report survey.
Beck C; Silverstone P; Glor K; Dunn J
Can J Psychiatry; 1999 Sep; 44(7):680-4. PubMed ID: 10500869
[TBL] [Abstract][Full Text] [Related]
14. Children's persistence with methylphenidate therapy: a population-based study.
Miller AR; Lalonde CE; McGrail KM
Can J Psychiatry; 2004 Nov; 49(11):761-8. PubMed ID: 15633854
[TBL] [Abstract][Full Text] [Related]
15. The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
Grimmsmann T; Himmel W
Eur J Clin Pharmacol; 2021 Jan; 77(1):107-115. PubMed ID: 32803292
[TBL] [Abstract][Full Text] [Related]
16. Current Australian pediatric practice in the assessment and treatment of ADHD.
Efron D; Davies S; Sciberras E
Acad Pediatr; 2013; 13(4):328-33. PubMed ID: 23830018
[TBL] [Abstract][Full Text] [Related]
17. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database.
Ashworth M; Latinovic R; Charlton J; Cox K; Rowlands G; Gulliford M
J Public Health (Oxf); 2004 Sep; 26(3):268-74. PubMed ID: 15454595
[TBL] [Abstract][Full Text] [Related]
18. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S
Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886
[TBL] [Abstract][Full Text] [Related]
19. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
Štuhec M; Locatelli I; Švab V
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
[TBL] [Abstract][Full Text] [Related]
20. [The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions].
Schmidt-Troschke SO; Ostermann T; Melcher D; Schuster R; Erben CM; Matthiessen PF
Gesundheitswesen; 2004 Jun; 66(6):387-92. PubMed ID: 15206042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
